ZTS Logo

Zoetis Inc. (ZTS) 

NYSE$163.75
Market Cap
$73.33B
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
924 of 924
Rank in Industry
56 of 56

ZTS Insider Trading Activity

ZTS Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$000
Sells
$1,128,6656100

Related Transactions

PECK KRISTIN CChief Executive Officer0$01$59,852$-59,852
Reed Willie Mdirector0$01$201,029$-201,029
Lagano RoxanneExecutive Vice President0$03$250,755$-250,755
Polzer Robert JExecutive Vice President0$01$617,028$-617,028

About Zoetis Inc.

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives â€¦

Insider Activity of Zoetis Inc.

Over the last 12 months, insiders at Zoetis Inc. have bought $0 and sold $1.13M worth of Zoetis Inc. stock.

On average, over the past 5 years, insiders at Zoetis Inc. have bought $2.5M and sold $44.58M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 15,180 shares for transaction amount of $2.5M was made by SCULLY ROBERT W (director) on 2021‑02‑19.

List of Insider Buy and Sell Transactions, Zoetis Inc.

2025-03-11SaleReed Willie Mdirector
1,210
0.0003%
$166.14$201,029-1.02%
2025-03-10SaleLagano RoxanneExecutive Vice President
326
<0.0001%
$170.00$55,420-4.69%
2025-02-19SalePECK KRISTIN CChief Executive Officer
382
<0.0001%
$156.68$59,852+5.58%
2025-02-11SaleLagano RoxanneExecutive Vice President
326
<0.0001%
$171.18$55,805-5.34%
2024-11-25SalePolzer Robert JExecutive Vice President
3,477
0.0008%
$177.46$617,028-6.15%
2024-04-18SaleLagano RoxanneExecutive Vice President
923
0.0002%
$151.17$139,530+14.68%
2024-03-18SaleLagano RoxanneExecutive Vice President
923
0.0002%
$173.33$159,984+2.58%
2024-03-11SaleReed Willie Mdirector
1,370
0.0003%
$182.68$250,265-4.41%
2024-02-20SalePECK KRISTIN CChief Executive Officer
13,000
0.0028%
$187.20$2.43M-5.40%
2024-02-20SaleLagano RoxanneExecutive Vice President
923
0.0002%
$187.30$172,878-5.40%
2024-02-13SaleLagano RoxanneExecutive Vice President
2,848
0.0006%
$186.86$532,177-3.66%
2024-02-12SaleLagano RoxanneExecutive Vice President
363
<0.0001%
$197.74$71,780-10.06%
2024-01-18SaleLagano RoxanneExecutive Vice President
923
0.0002%
$191.43$176,690-6.41%
2023-12-18SaleLagano RoxanneExecutive Vice President
923
0.0002%
$198.14$182,883-7.70%
2023-12-14SaleLagano RoxanneExecutive Vice President
2,500
0.0005%
$200.00$500,000-9.07%
2023-11-21SalePECK KRISTIN CChief Executive Officer
13,000
0.0028%
$176.84$2.3M+2.17%
2023-11-17SaleLagano RoxanneExecutive Vice President
923
0.0002%
$177.46$163,796+4.55%
2023-10-18SaleLagano RoxanneExecutive Vice President
923
0.0002%
$172.92$159,605+7.53%
2023-09-18SaleLagano RoxanneExecutive Vice President
923
0.0002%
$179.58$165,752-0.82%
2023-09-15SaleChen Heidi C.Executive Vice President
9,905
0.0022%
$180.15$1.78M-1.28%
Total: 192
*Gray background shows transactions not older than one year

Insider Historical Profitability

4.78%
Lagano RoxanneExecutive Vice President
15781
0.0035%
$2.58M141+3.05%
Pershing Square Capital Management, L.P.director
24973145
5.577%
$4.09B12<0.0001%
Knupp Catherine A.Executive Vice President
43642
0.0097%
$7.15M18+3.05%
Lewis Clinton A. Jr.Executive Vice President
27904
0.0062%
$4.57M112+3.05%
Chen Heidi C.Executive Vice President
27478
0.0061%
$4.5M127+3.05%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$910,099,463
123
11.52%
$2.58B
$23,522,750
59
-6.74%
$5.36B
$14,599,168
59
12.79%
$1.41B
$86,177,559
48
44.65%
$13.99B
$97,642,477
41
-10.58%
$856.51M

ZTS Institutional Investors: Active Positions

Increased Positions918+46.46%32M+7.57%
Decreased Positions876-44.33%31M-7.33%
New Positions247New10MNew
Sold Out Positions148Sold Out4MSold Out
Total Postitions2,018+2.13%421M+0.24%

ZTS Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$6.67M9.23%41.37M+120,158+0.29%2024-12-31
Blackrock, Inc.$6.24M8.64%38.71M+476,495+1.25%2024-12-31
State Street Corp$3.2M4.43%19.84M+63,502+0.32%2024-12-31
State Farm Mutual Automobile Insurance Co$2.58M3.57%16.01M-26,093-0.16%2024-12-31
Morgan Stanley$1.91M2.64%11.84M-197,357-1.64%2024-12-31
Alliancebernstein L.P.$1.9M2.64%11.81M-4M-23.26%2024-12-31
Bank Of America Corp /De/$1.85M2.57%11.5M-3M-19.93%2024-12-31
Geode Capital Management, Llc$1.71M2.37%10.62M+190,137+1.82%2024-12-31
Polen Capital Management Llc$1.21M1.67%7.48M+1M+17.54%2024-12-31
Wellington Management Group Llp$1.12M1.55%6.96M+3M+78.46%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
2SellsBuysStrong BuyBuyHoldSellStrong SellZTSHighAverageLowSeries 4